Dendritic cell-based immunotherapy in myeloid leukaemia: translating fundamental mechanisms into clinical applications

The efficient generation of immunocompetent dendritic cells from leukemic blasts in acute myeloid leukemia: a local experience

Dendritic cell vaccines in acute leukaemia

Potential of dendritic-cell immunotherapy for relapse after allogeneic hematopoietic stem cell transplantation, shown by WT1 peptide- and keyhole-limpet-hemocyanin-pulsed, donor-derived dendritic-cell vaccine for acute myeloid leukemia

Efficient monocyte-derived dendritic cell generation in patients with acute myeloid leukemia after chemotherapy treatment: application to active immunotherapy

Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia

Large-scale generation of autologous dendritic cells for immunotherapy in patients with acute myeloid leukemia

Dendritic cell vaccines for leukemia patients

Dendritic cell-based immunotherapy in acute and chronic myeloid leukaemia

Generation of functional dendritic cells (DC) in adult acute lymphoblastic leukemia: rationale for a DC-based vaccination program for patients in complete hematological remission